Far Infrared Radiation Treatment for Prostate Cancer

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Prostate Cancer

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00573820

Enrollment

Registered

2007-12-14

Start date

2006-01-31

Completion date

2008-12-31

Last updated

2009-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Neoplasms

Keywords

Tumors or cancer of the prostate, Cancer of Prostate, Cancer of the Prostate, Neoplasms, Prostate, Neoplasms, Prostatic, Prostate Cancer, Prostate Neoplasms, Prostatic Cancer

Brief summary

A study to determine the use of far infrared radiation for the treatment of prostate cancer.

Detailed description

Our initial assessment indicates that electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to cure a number of diseases, including prostate cancer.

Interventions

RADIATIONFar Infrared Radiation

Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each treatment session.

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Healthy volunteers

Inclusion criteria

* Persons with Prostate, Bladder or Testicular Cancer.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
The primary end point is to determine the therapeutic effects of far infrared radiation on Prostate Cancer.	2 years and 6 months

Secondary

Measure	Time frame
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other types of cancer (Bladder and Testis).	2 years and 6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026